Nishadil
Signup Signin
Delhi | 25°C (windy)
A Shot in the Arm for Purple Biotech: Unpacking the Hype Around a Promising Cancer Drug

A Shot in the Arm for Purple Biotech: Unpacking the Hype Around a Promising Cancer Drug
A Setback on the Cancer Front: The Unfolding Story of Keytruda and Lenvima

A Setback on the Cancer Front: The Unfolding Story of Keytruda and Lenvima
A Major Setback: Moderna's Highly Anticipated CMV Vaccine Fails Key Efficacy Goal in Phase 3

A Major Setback: Moderna's Highly Anticipated CMV Vaccine Fails Key Efficacy Goal in Phase 3
Revolution Medicines Soars as Darovasertib's Stellar Data Paves Way for Phase 3 in Uveal Melanoma

Revolution Medicines Soars as Darovasertib's Stellar Data Paves Way for Phase 3 in Uveal Melanoma
Wells Fargo Crowns Axsome Therapeutics a Biotech Heavyweight with 'Overweight' Rating on Blockbuster Alzheimer's Potential

Wells Fargo Crowns Axsome Therapeutics a Biotech Heavyweight with 'Overweight' Rating on Blockbuster Alzheimer's Potential
Groundbreaking Cancer Drug Ivonescimab Propels Akeso Shares After Major Clinical Trial Success

Groundbreaking Cancer Drug Ivonescimab Propels Akeso Shares After Major Clinical Trial Success
Talphaera's Q2 2025: Unpacking Financials & Pioneering Biotech Advancements

Talphaera's Q2 2025: Unpacking Financials & Pioneering Biotech Advancements
Load more..